Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 開頭術 | から $28,500 | から $5,650 | から $20,000 |
| 脳腫瘍摘出術 | から $38,500 | から $19,710 | から $60,000 |
| 下垂体腫瘍摘出術 | から $28,000 | から $13,500 | から $30,000 |
| ガンマナイフ | から $13,800 | から $6,300 | から $32,000 |
| 経鼻的腫瘍切除術 | - | から $8,000 | から $30,000 |
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
この医師は、著名な神経外科医であり、現在、European Association of Neurosurgical Societies (EANS) の会長を務めています。テルアビブ大学のサックラー医学部を卒業し、チャイム・シェバ医療センターでのローテーションインターンシップを修了し、アメリカのAmerican Association of Neurosurgeryと協力しました。動脈瘤、脳血管病変、脳腫瘍、最小侵襲の脳および脊椎手術などの疾患を専門とし、脳マッピングや深部脳刺激 (DBS) にも精通しています。神経学への貢献により、ボレンスタイン賞とゴールドヒルシュ財団賞を受賞しています。
Sourasky Medical Center, Hadassah Medical Center, and Assuta Medical Center are Israel's premier facilities for pituitary adenoma treatment. These JCI-accredited institutions specialize in endoscopic transnasal resection. This minimally invasive approach allows surgeons to remove tumors through the nasal cavity without external incisions.
Bookimed Expert Insight: Sourasky Medical Center stands out because it integrates massive patient volumes with research-led care. They serve over 1.8 million patients yearly and perform 34,000 surgeries. This high frequency allows specialists like Dr. Zvi Ram to maintain expertise in complex, recurrent adenomas. Patients benefit from this concentrated experience, as surgeons manage more rare cases than smaller regional centers.
Patient Consensus: Patients note that Israeli centers often suggest aggressive minimally invasive surgery when other countries recommend waiting. Successful outcomes include hormone levels normalizing within months and significantly shorter recovery times.
A pituitary adenoma is not cancerous. These tumors are almost always benign and originate in glandular tissue. They grow slowly and do not spread to distant organs. Malignant cases, called pituitary carcinomas, represent less than 0.1% of all diagnosed pituitary growths.
Bookimed Expert Insight: Clinical data from major Israeli centers shows a strong trend toward minimally invasive techniques. Prof. Margalit Navo at Sourasky Medical Center has performed over 100 successful skull base surgeries. Similarly, Dr. Samuel Moskovichi at Hadassah Medical Center focuses on transnasal endoscopic access. This approach allows surgeons to remove benign tumors through the nose without external incisions. This significantly reduces recovery time compared to traditional craniotomy.
Patient Consensus: Many patients initially confuse the word tumor with cancer, but doctors quickly clarify that adenomas are benign. Those treated in Israel emphasize that even large 3cm tumors are usually non-cancerous and manageable with medication like cabergoline.
Primary treatment for pituitary adenoma in Israel focuses on minimally invasive transnasal resection and specialized medical management. Surgeons at JCI-accredited centers like Sourasky Medical Center achieve a 90% success rate by removing tumors through the nasal cavity. This approach eliminates external scarring and shortens hospital stays to 3 days.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization, with experts like Dr. Margalit Navo performing over 100 skull base procedures. Data shows that private facilities like Assuta Medical Center handle 92,000 operations annually, allowing patients to select specific senior surgeons. This choice is vital because outcomes improve significantly when a neurosurgeon performs more than 50 adenoma resections per year.
Patient Consensus: Patients note that recovery from endoscopic surgery is remarkably fast, often returning home within 72 hours. Many emphasize the importance of choosing English-fluent multidisciplinary teams to coordinate between neurosurgery and endocrinology specialists effectively.
Israeli neurosurgeons prioritise minimally invasive endoscopic endonasal surgery for pituitary adenomas. This technique accesses tumours through the nostrils. It avoids skull incisions and protects brain tissue. Surgeons often use intraoperative MRI and navigation systems to preserve healthy structures during these high-precision procedures.
Bookimed Expert Insight: Israeli neurosurgery centres like Sourasky and Sheba maintain extremely high surgical volumes, with some performing over 34,000 operations annually. This immense volume allows surgeons like Dr Margalit Navo to specialise deeply in niche areas like skull base diseases. For patients, this translates to specialised expertise that is often harder to find in lower-volume regional hospitals.
Patient Consensus: Patients in Israel note that the endonasal approach effectively eliminates visible scarring. They emphasise the importance of planning for nasal discomfort and fatigue during the initial recovery phase.
Not all pituitary tumours in Israel require surgery. Specialists use a multidisciplinary approach including observation, medication, and targeted radiation. Treatment choice depends on tumour type, hormone activity, and size. Israeli centres like Sheba Medical Centre and Sourasky Medical Centre prioritise minimally invasive methods when intervention is necessary.
Bookimed Expert Insight: Israeli neurosurgery stands out because of the high concentration of Australian-trained expertise. For example, Dr Andry Key at Hadassah Medical Centre previously led the neurosurgery department at the Royal Melbourne Hospital. This connection ensures that Australian patients receive care aligned with familiar medical standards while benefiting from Israel's high-volume experience in complex skull-base cases.
Patient Consensus: Patients note that Israel offers a comprehensive endocrine plan rather than rushing into theatre. They appreciate how coordinators at Sourasky Medical Centre manage logistics quickly during local disruptions, highlighting the importance of long-term hormone monitoring after treatment.
No, a pituitary adenoma is not considered brain cancer. It is a benign, non-cancerous growth of glandular tissue. While grouped with brain tumours due to its location inside the skull, it does not spread like malignant cancer cells do.
Bookimed Expert Insight: Australian patients find a unique level of familiarity at Hadassah Medical Center. Dr Andry Key, a neurosurgeon there with over 45 years of experience, was trained at the University of Melbourne and previously headed neurosurgery at the Royal Melbourne Hospital. Dealing with a specialist who understands the Australian medical system can significantly ease the stress of international treatment.
Patient Consensus: While generally benign, patients in Israel quickly learn that pituitary adenomas require intensive, long-term endocrine care. Common experiences include managing severe exhaustion, vision shifts, and hormone-related weight changes alongside their surgical recovery.
Long-term hormone replacement therapy depends on whether the pituitary gland recovers function after surgery or radiation. Many patients require lifelong support if the tumour permanently damaged the gland. Specialists in Israel monitor hormone levels for months post-treatment to determine if function returns.
Bookimed Expert Insight: Australian patients find high relevance at Hadassah Medical Center because of Dr Andry Key. He was the former Head of Neurosurgery at Royal Melbourne Hospital. His presence bridges the gap between Australian surgical standards and Israeli advanced neuro-oncology protocols. This familiarity often helps patients navigate complex long-term endocrine follow-up plans more confidently.
Patient Consensus: Patients in Israel note that hormone levels can recover at different speeds across different axes. They emphasise that ongoing surveillance and regular endocrine appointments are a necessary long-term commitment.
Radiation therapy in Israel treats pituitary adenomas when surgery cannot safely remove the entire tumour or when medication fails to control hormone levels. Specialists use Gamma Knife or stereotactic radiotherapy to target residual or recurring growths. This precision treatment stops tumour expansion while sparing nearby healthy brain tissue.
Bookimed Expert Insight: Israeli neurosurgeons like Dr Andry Key at Hadassah Medical Center often combine Australian training with Israeli technology. This cross-continental experience is vital for complex pituitary cases where tumours press on the cavernous sinus. Surgeons here frequently manage patients who require both microsurgery and delayed radiotherapy for long-term control.
Patient Consensus: Patients in Israel note that radiation works slowly and requires ongoing endocrine follow-up. They appreciate how coordinators quickly manage logistics, even during local strikes, so MRI monitoring remains on schedule.
International patients treated for pituitary adenoma in Israel typically stay for 14 to 21 days. This timeframe covers neurosurgical consultations, advanced MRI imaging, and a recovery buffer. Complex cases involving craniotomy may require longer periods. Tourist visas allow stays up to 90 days.
Bookimed Expert Insight: Israeli neurosurgery packages offer a specific advantage for Australians. Facilities like Sheba Medical Center bundle 10 hotel days into their surgical plans. This built-in buffer facilitates the mandatory wound checks and endocrinology reviews required before a 20-hour return journey.
Patient Consensus: Patients note it is important to avoid booking return flights early and to include extra days for specialist reviews. They appreciate how coordinators quickly manage scheduling changes when local events affect clinic timings in Israel.
Israel's top hospitals for pituitary adenoma treatment include Sheba Medical Center, Sourasky Medical Center, and Hadassah Medical Center. These JCI-accredited facilities specialise in endoscopic transsphenoidal surgery. This technique removes tumours through the nose. Experienced neurosurgeons lead multidisciplinary teams to ensure precise tumour resection and hormonal balance.
Bookimed Expert Insight: While many hospitals offer general neurosurgery, Sheba Medical Center stands out for research. It founded a dedicated brain tumour tissue bank. This depth of data helps their specialists like Dr Zvi Cohen, a Forbes-listed expert, refine surgical approaches for rare or complex pituitary cases.
Patient Consensus: Patients note the efficiency of international coordinators in Israel when handling logistics during travel disruptions. They highlight that choosing teams with heavy endocrine support is vital for managing hormones after surgery.